We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
(+8.7%)
Cap. Flow
+$4.56B
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$526M |
| 2 |
US Bancorp
USB
|
+$301M |
| 3 |
Pultegroup
PHM
|
+$217M |
| 4 |
BATS
Bats Global Markets, Inc.
BATS
|
+$145M |
| 5 |
Charter Communications
CHTR
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARG
Airgas Inc
ARG
|
+$477M |
| 2 |
Pfizer
PFE
|
+$305M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$294M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$275M |
| 5 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.61% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 7.19% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Lakeland Financial Corp
LKFN
$1.57B
| $876K | ﹤0.01% |
27,959
+12,065
| +76% | +$379K |
|
2902
MacroGenics
MGNX
$233M
| $876K | ﹤0.01% |
32,479
-1,659
| -5% | -$37.4K |
|
|
LABL
2903
DELISTED
Multi-Color Corp
LABL
| $876K | ﹤0.01% |
13,804
-1,951
| -12% | -$115K |
|
2904
Nelnet
NNI
$4.96B
| $875K | ﹤0.01% |
25,202
-4,441
| -15% | -$166K |
|
|
EXK
2905
Endeavour Silver
EXK
$2.24B
| $874K | ﹤0.01% |
221,200
-34,980
| -14% | -$122K |
|
2906
Lexicon Pharmaceuticals
LXRX
$1.03B
| $873K | ﹤0.01% |
60,826
-47,152
| -44% | -$640K |
|
|
SASR
2907
DELISTED
Sandy Spring Bancorp Inc
SASR
| $873K | ﹤0.01% |
30,045
+17,200
| +134% | +$488K |
|
2908
Andersons Inc
ANDE
$2.39B
| $872K | ﹤0.01% |
24,535
-9,814
| -29% | -$321K |
|
2909
eHealth
EHTH
$41.9M
| $868K | ﹤0.01% |
+61,922
| New | +$752K |
|
|
HEES
2910
DELISTED
H&E Equipment Services
HEES
| $867K | ﹤0.01% |
45,563
+22,240
| +95% | +$418K |
|
2911
Seaboard Corp
SEB
$4.39B
| $867K | ﹤0.01% |
302
+194
| +180% | +$569K |
|
2912
Astronics
ATRO
$3.21B
| $866K | ﹤0.01% |
41,352
+14,343
| +53% | +$330K |
|
2913
Veeco
VECO
$2.62B
| $865K | ﹤0.01% |
52,213
+26,351
| +102% | +$469K |
|
2914
DHI Group
DHX
$177M
| $864K | ﹤0.01% |
138,801
+114,072
| +461% | +$818K |
|
2915
Atkore
ATKR
$2.41B
| $862K | ﹤0.01% |
+53,879
| New | +$871K |
|
|
CEMP
2916
DELISTED
Cempra, Inc.
CEMP
| $860K | ﹤0.01% |
52,074
+2,717
| +6% | +$47.9K |
|
2917
World Acceptance Corp
WRLD
$861M
| $859K | ﹤0.01% |
18,860
-20,965
| -53% | -$852K |
|
|
KERX
2918
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $856K | ﹤0.01% |
129,319
-22,107
| -15% | -$124K |
|
2919
Scholastic
SCHL
$774M
| $854K | ﹤0.01% |
21,543
+7,826
| +57% | +$295K |
|
|
MNDT
2920
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $853K | ﹤0.01% |
51,800
+1,800
| +4% | +$29.1K |
|
|
ISD
2921
PGIM High Yield Bond Fund
ISD
$414M
| $848K | ﹤0.01% |
53,734
| – | – |
|
|
CSII
2922
DELISTED
Cardiovascular Systems, Inc.
CSII
| $847K | ﹤0.01% |
46,111
+30,723
| +200% | +$480K |
|
|
WAIR
2923
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $846K | ﹤0.01% |
62,963
+36,707
| +140% | +$523K |
|
|
GNRT
2924
DELISTED
Gener8 Maritime, Inc.
GNRT
| $844K | ﹤0.01% |
131,917
+107,955
| +451% | +$766K |
|
|
ARRY
2925
DELISTED
Array Biopharma Inc
ARRY
| $843K | ﹤0.01% |
236,532
+10,503
| +5% | +$34.2K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2016 Portfolio in Review
As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.
- Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
- Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
- Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
- Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
- Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
- Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.
Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.